Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cypropofol plus remifentanil versus propofol plus remifentanil for laparoscopic colon cancer surgery
ChiCTR2300067398Phase 4Not yet recruiting
- Sponsor
- Bethune International Peace Hospital
- Start
- Jan 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ciprofol, propofol and remifentanil (2 arms), sponsored by Bethune International Peace Hospital. Primary endpoints: QoR15 score and Anesthetic adverse reaction. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
ciprofolpropofolremifentanil
Beyond the preview
Go deeper on ChiCTR2300067398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067398.